These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 7694295

  • 1. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells.
    Read MA, Cordle SR, Veach RA, Carlisle CD, Hawiger J.
    Proc Natl Acad Sci U S A; 1993 Nov 01; 90(21):9887-91. PubMed ID: 7694295
    [Abstract] [Full Text] [Related]

  • 2. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14.
    Loppnow H, Stelter F, Schönbeck U, Schlüter C, Ernst M, Schütt C, Flad HD.
    Infect Immun; 1995 Mar 01; 63(3):1020-6. PubMed ID: 7532623
    [Abstract] [Full Text] [Related]

  • 3. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.
    Pugin J, Schürer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS.
    Proc Natl Acad Sci U S A; 1993 Apr 01; 90(7):2744-8. PubMed ID: 7681988
    [Abstract] [Full Text] [Related]

  • 4. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein.
    Lee JD, Kato K, Tobias PS, Kirkland TN, Ulevitch RJ.
    J Exp Med; 1992 Jun 01; 175(6):1697-705. PubMed ID: 1375269
    [Abstract] [Full Text] [Related]

  • 5. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide.
    Camussi G, Mariano F, Biancone L, De Martino A, Bussolati B, Montrucchio G, Tobias PS.
    J Immunol; 1995 Jul 01; 155(1):316-24. PubMed ID: 7541418
    [Abstract] [Full Text] [Related]

  • 6. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.
    Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, Busse LA, Zukowski MM, Wright SD.
    J Exp Med; 1994 Jan 01; 179(1):269-77. PubMed ID: 7505800
    [Abstract] [Full Text] [Related]

  • 7. Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin.
    Lee JD, Kravchenko V, Kirkland TN, Han J, Mackman N, Moriarty A, Leturcq D, Tobias PS, Ulevitch RJ.
    Proc Natl Acad Sci U S A; 1993 Nov 01; 90(21):9930-4. PubMed ID: 7694296
    [Abstract] [Full Text] [Related]

  • 8. Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding.
    Juan TS, Hailman E, Kelley MJ, Wright SD, Lichenstein HS.
    J Biol Chem; 1995 Jul 21; 270(29):17237-42. PubMed ID: 7542233
    [Abstract] [Full Text] [Related]

  • 9. Soluble CD14 in serum mediates LPS-induced increase in permeability of bovine pulmonary arterial endothelial cell monolayers in vitro.
    Ishii Y, Shuyi W, Kitamura S.
    Life Sci; 1995 Jul 21; 56(25):2263-72. PubMed ID: 7540708
    [Abstract] [Full Text] [Related]

  • 10. CD14-mediated translocation of nuclear factor-kappa B induced by lipopolysaccharide does not require tyrosine kinase activity.
    Delude RL, Fenton MJ, Savedra R, Perera PY, Vogel SN, Thieringer R, Golenbock DT.
    J Biol Chem; 1994 Sep 02; 269(35):22253-60. PubMed ID: 7520914
    [Abstract] [Full Text] [Related]

  • 11. Soluble CD14 participates in the response of cells to lipopolysaccharide.
    Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, Finlay BB, Wright SD.
    J Exp Med; 1992 Dec 01; 176(6):1665-71. PubMed ID: 1281215
    [Abstract] [Full Text] [Related]

  • 12. Soluble CD14 and lipopolysaccharide-binding protein from bovine serum enable bacterial lipopolysaccharide-mediated cytotoxicity and activation of bovine vascular endothelial cells in vitro.
    Yang Z, Breider MA, Carroll RC, Miller MS, Bochsler PN.
    J Leukoc Biol; 1996 Feb 01; 59(2):241-7. PubMed ID: 8603996
    [Abstract] [Full Text] [Related]

  • 13. A region of human CD14 required for lipopolysaccharide binding.
    Viriyakosol S, Kirkland TN.
    J Biol Chem; 1995 Jan 06; 270(1):361-8. PubMed ID: 7529231
    [Abstract] [Full Text] [Related]

  • 14. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation.
    Pugin J, Ulevitch RJ, Tobias PS.
    J Exp Med; 1993 Dec 01; 178(6):2193-200. PubMed ID: 7504060
    [Abstract] [Full Text] [Related]

  • 15. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.
    Kitchens RL, Ulevitch RJ, Munford RS.
    J Exp Med; 1992 Aug 01; 176(2):485-94. PubMed ID: 1380063
    [Abstract] [Full Text] [Related]

  • 16. Lipopolysaccharide (LPS) binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14.
    Han J, Mathison JC, Ulevitch RJ, Tobias PS.
    J Biol Chem; 1994 Mar 18; 269(11):8172-5. PubMed ID: 7510680
    [Abstract] [Full Text] [Related]

  • 17. Soluble CD14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS.
    Juan TS, Kelley MJ, Johnson DA, Busse LA, Hailman E, Wright SD, Lichenstein HS.
    J Biol Chem; 1995 Jan 20; 270(3):1382-7. PubMed ID: 7530712
    [Abstract] [Full Text] [Related]

  • 18. Suppression of TNF-alpha mRNA expression in LPS-primed macrophages occurs at the level of nuclear factor-kappa B activation, but not at the level of protein kinase C or CD14 expression.
    Takasuka N, Matsuura K, Yamamoto S, Akagawa KS.
    J Immunol; 1995 May 01; 154(9):4803-12. PubMed ID: 7536782
    [Abstract] [Full Text] [Related]

  • 19. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells.
    Golenbock DT, Bach RR, Lichenstein H, Juan TS, Tadavarthy A, Moldow CF.
    J Lab Clin Med; 1995 May 01; 125(5):662-71. PubMed ID: 7537790
    [Abstract] [Full Text] [Related]

  • 20. Activation of human endothelial cells by viable or heat-killed gram-negative bacteria requires soluble CD14.
    Noel RF, Sato TT, Mendez C, Johnson MC, Pohlman TH.
    Infect Immun; 1995 Oct 01; 63(10):4046-53. PubMed ID: 7558318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.